MX2012012479A - Metodos, composiciones y accesorios para proporcionar un tratamiento terapeutico. - Google Patents
Metodos, composiciones y accesorios para proporcionar un tratamiento terapeutico.Info
- Publication number
- MX2012012479A MX2012012479A MX2012012479A MX2012012479A MX2012012479A MX 2012012479 A MX2012012479 A MX 2012012479A MX 2012012479 A MX2012012479 A MX 2012012479A MX 2012012479 A MX2012012479 A MX 2012012479A MX 2012012479 A MX2012012479 A MX 2012012479A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- kits
- compositions
- methods
- providing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 229940043671 antithyroid preparations Drugs 0.000 abstract 3
- 239000003200 antithyroid agent Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 abstract 1
- 230000003208 anti-thyroid effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- XMBWDFGMSWQBCA-RNFDNDRNSA-M iodine-131(1-) Chemical compound [131I-] XMBWDFGMSWQBCA-RNFDNDRNSA-M 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 210000001685 thyroid gland Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención abarca un método terapéutico que emplea tratamiento de una enfermedad tal como el cáncer con triyodotronina (T3) junto con un tratamiento antitiroideo tal como tratamiento con un agente antitiroideo, tratamiento con yodo radiactivo y extirpación quirúrgica de todo o parte de la glándula tiroidea. La invención también abarca una composición farmacéutica que comprende T3 y un agente antitiroideo y un kit que comprende la misma.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32882510P | 2010-04-28 | 2010-04-28 | |
| PCT/IL2011/000346 WO2011135574A1 (en) | 2010-04-28 | 2011-04-28 | Methods, compositions and kits for providing a therapeutic treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012012479A true MX2012012479A (es) | 2013-07-03 |
Family
ID=44860959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012012479A MX2012012479A (es) | 2010-04-28 | 2011-04-28 | Metodos, composiciones y accesorios para proporcionar un tratamiento terapeutico. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9655984B2 (es) |
| EP (1) | EP2563120B1 (es) |
| JP (1) | JP5921529B2 (es) |
| KR (1) | KR101841304B1 (es) |
| CN (1) | CN102858156B (es) |
| AU (1) | AU2011246851B2 (es) |
| BR (1) | BR112012027463A2 (es) |
| CA (1) | CA2797625C (es) |
| ES (1) | ES2791708T3 (es) |
| MX (1) | MX2012012479A (es) |
| WO (1) | WO2011135574A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ721500A (en) | 2014-02-10 | 2022-11-25 | Fred Hutchinson Cancer Center | Use of halogen compounds for the treatment and prevention of heart attack and ischemic injury |
| CN105486869A (zh) * | 2014-10-08 | 2016-04-13 | 江苏维赛科技生物发展有限公司 | 一种检测动物源食品中甲巯咪唑残留的酶联免疫试剂盒及其应用 |
| US20200222348A1 (en) * | 2017-05-08 | 2020-07-16 | Musli Thyropeutics Ltd. | Bimodal modified release compositions for cancer treatment |
| WO2021257806A1 (en) * | 2020-06-18 | 2021-12-23 | Fred Hutchinson Cancer Research Center | Iodide for treatment of nonthyroidal illness syndrome |
| CN114605278A (zh) * | 2022-02-11 | 2022-06-10 | 天津市肿瘤医院（天津医科大学肿瘤医院） | T3或其可药用盐在制备脑胶质瘤放化疗药物方面的应用 |
| CN114878840A (zh) * | 2022-07-12 | 2022-08-09 | 昆明思安生物科技有限公司 | 磁微粒化学发光测定三碘甲状腺原氨酸试剂盒及检测方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB851610A (en) | 1956-03-07 | 1960-10-19 | Gunther Hillman | Method for producing iodine derivatives of thyronine |
| US4426453A (en) | 1980-09-18 | 1984-01-17 | Amersham International Limited | Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds |
| JPH07116031B2 (ja) | 1986-09-24 | 1995-12-13 | 株式会社アドバンス | 制癌剤 |
| US6017958A (en) | 1996-06-04 | 2000-01-25 | Octamer, Inc. | Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity |
| CA2384713A1 (en) * | 1999-09-29 | 2001-04-05 | Human Genome Sciences, Inc. | Colon and colon cancer associated polynucleotides and polypeptides |
| US6939863B2 (en) * | 2002-01-04 | 2005-09-06 | Wei-Jan Chen | Prevention of atherosclerosis and restenosis |
| US7074426B2 (en) * | 2002-03-27 | 2006-07-11 | Frank Kochinke | Methods and drug delivery systems for the treatment of orofacial diseases |
| EP1929030A2 (en) * | 2005-09-08 | 2008-06-11 | Shire LLC | Prodrugs of t3 and t4 with enhanced bioavailability |
-
2011
- 2011-04-28 MX MX2012012479A patent/MX2012012479A/es not_active Application Discontinuation
- 2011-04-28 WO PCT/IL2011/000346 patent/WO2011135574A1/en active Application Filing
- 2011-04-28 CA CA2797625A patent/CA2797625C/en not_active Expired - Fee Related
- 2011-04-28 JP JP2013506810A patent/JP5921529B2/ja not_active Expired - Fee Related
- 2011-04-28 AU AU2011246851A patent/AU2011246851B2/en not_active Ceased
- 2011-04-28 BR BR112012027463A patent/BR112012027463A2/pt not_active Application Discontinuation
- 2011-04-28 US US13/643,907 patent/US9655984B2/en active Active
- 2011-04-28 KR KR1020127030962A patent/KR101841304B1/ko active IP Right Grant
- 2011-04-28 CN CN201180020423.4A patent/CN102858156B/zh not_active Expired - Fee Related
- 2011-04-28 EP EP11774538.0A patent/EP2563120B1/en active Active
- 2011-04-28 ES ES11774538T patent/ES2791708T3/es active Active
-
2017
- 2017-04-11 US US15/484,691 patent/US10398789B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2563120A1 (en) | 2013-03-06 |
| US9655984B2 (en) | 2017-05-23 |
| KR101841304B1 (ko) | 2018-03-22 |
| CN102858156A (zh) | 2013-01-02 |
| AU2011246851A1 (en) | 2012-11-15 |
| EP2563120A4 (en) | 2015-05-13 |
| JP5921529B2 (ja) | 2016-05-24 |
| ES2791708T3 (es) | 2020-11-05 |
| CN102858156B (zh) | 2015-09-23 |
| KR20130103336A (ko) | 2013-09-23 |
| AU2011246851B2 (en) | 2016-07-21 |
| EP2563120B1 (en) | 2020-02-26 |
| JP2013525422A (ja) | 2013-06-20 |
| US20130129615A1 (en) | 2013-05-23 |
| BR112012027463A2 (pt) | 2015-09-29 |
| US10398789B2 (en) | 2019-09-03 |
| CA2797625C (en) | 2019-08-20 |
| WO2011135574A1 (en) | 2011-11-03 |
| US20170274104A1 (en) | 2017-09-28 |
| CA2797625A1 (en) | 2011-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX346450B (es) | Composiciones y métodos para el tratamiento de la enfermedad celíaca. | |
| PH12015501744A1 (en) | Therapeutic and diagnostic target for cancer comprising dll3 binding reagents | |
| BR112012020304A2 (pt) | complexo que alveja tecido, uso de um complexo que alveja tecido, método de tratamento de um corpo de animal humano ou não humano, composição farmacêutica, e, kit | |
| MX2013010343A (es) | Composicion y metodos para el transplante de microbiota de colon. | |
| PH12020551043A1 (en) | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues | |
| UA103319C2 (en) | Thiazole- and oxazole-benzene sulfonamide compounds | |
| BR112014021498A2 (pt) | composto, composição e método para tratar uma doença associada com formação de dna circular covalentemente fechado | |
| NZ707086A (en) | Anti-cd40 antibodies and methods of use | |
| SG194701A1 (en) | Anti-cd40 antibodies and methods of use | |
| EA201390145A1 (ru) | Конъюгаты, частицы, композиции и связанные с ними способы | |
| MX355543B (es) | Macrociclos peptidomiméticos. | |
| BR112017027954A2 (pt) | métodos de tratamento de tumores de célula epitelioide | |
| MA34057B1 (fr) | Compositions et methodes pour le diagnostic et le traitement d'une tumeur | |
| MX343135B (es) | Compuestos de tipo fumagilol y métodos de realización y uso de los mismos. | |
| EA201201400A1 (ru) | Композиции и способы лечения аутоиммунных и других заболеваний | |
| BR112015011756A2 (pt) | inibidores da glutamase e métodos de uso | |
| EA201300171A1 (ru) | Способы и композиции для терапии рака печени | |
| MY157341A (en) | Methods and compositions for treating lung cancer | |
| WO2012024530A3 (en) | Therapeutic peptide-polymer conjugates, particles, compositions, and related methods | |
| EA201200046A1 (ru) | Новые соединения, фармацевтическая композиция и связанные с ними способы | |
| GB2497475A (en) | Kits, components and methods for tissue reconstruction | |
| MX2012012479A (es) | Metodos, composiciones y accesorios para proporcionar un tratamiento terapeutico. | |
| MX2013000958A (es) | Fabricación del inhibidor-inter-alfa (iaip) a partir de plasma. | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| EA201492187A1 (ru) | Способы лечения солидных опухолей с использованием кофермента q10 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |